Carbidopa/Levodopa
- Generic Name
- Carbidopa/Levodopa
Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing
Phase 4
Terminated
- Conditions
- Depressive Disorder
- Interventions
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 1
- Registration Number
- NCT04650217
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
Phase 4
Terminated
- Conditions
- Cognitive ImpairmentDepressionGait Impairment
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-07-30
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 5
- Registration Number
- NCT04493320
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
Effect of L-dopa In Subacute Back Pain Population
Phase 4
Completed
- Conditions
- Sub-acute Back Pain
- Interventions
- First Posted Date
- 2013-09-26
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 72
- Registration Number
- NCT01951105
- Locations
- ๐บ๐ธ
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
Phase 4
Withdrawn
- Conditions
- Parkinson's Disease
- Interventions
- Drug: Carbidopa/Levodopa/Entacapone
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Novartis Pharmaceuticals
- Registration Number
- NCT00601978
Treatment of Orthostatic Hypotension in Autonomic Failure
Phase 1
Completed
- Conditions
- Autonomic FailureOrthostatic Hypotension
- Interventions
- Drug: placeboDevice: inflatable abdominal binder (sham)Other: water intakeDietary Supplement: BovrilDevice: Inflatable abdominal binder
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 389
- Registration Number
- NCT00223691
- Locations
- ๐บ๐ธ
Vanderbilt University, Nashville, Tennessee, United States
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Not Applicable
Completed
- Conditions
- Parkinson DiseaseParkinsonian Syndrome
- First Posted Date
- 2005-08-11
- Last Posted Date
- 2009-08-28
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 30
- Registration Number
- NCT00129181
- Locations
- ๐ฉ๐ช
Dept. of Neurology, University of Leipzig, Leipzig, Germany
๐ฎ๐นDepartment of Neurological Sciences-University of Napoli, Naples, Italy
๐ฉ๐ชDept. of Neurology Marburg, Phillips-Univ., Marburg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath